Lonza agreed to buy a manufacturing facility in the U.S. from Roche for around $1.2 billion in cash as it seeks to grow its biologics division.
Lonza to Boost Biologics Sales With Manufacturing Facility Buy
Lonza agreed to buy a manufacturing facility in the U.S. from Roche for around $1.2 billion in cash as it seeks to grow its biologics division.
